锌指蛋白703在卵巢上皮性浆液性肿瘤中的表达及临床意义
王爽1,2, 汪彩霞3, 李潇1,2, 刘鸥萱1,2, 胡悦欣1,2, 勾睿1,2, 聂鑫1,2, 郭骞1,2, 朱连成1,2, 林蓓1,21. 中国医科大学附属盛京医院妇产科, 沈阳 110004;
2. 辽宁省母胎医学重点实验室, 辽宁省妇产科学重点实验室, 沈阳 110004;
3. 四川大学华西第二医院妇产科, 成都 610041
收稿日期:
2021-03-29出版日期:
2022-01-30发布日期:
2021-12-30通讯作者:
林蓓E-mail:prof_linbei@126.com作者简介:
王爽(1993-),女,博士研究生.基金资助:
国家自然科学基金(81672590,81472437);盛京自由研究者计划(201804)关键词: 卵巢上皮性浆液性肿瘤, 免疫组织化学, 锌指蛋白703
Abstract: Objective To investigate expression of zinc finger protein 703(ZNF703)in ovarian epithelial serous tumor tissue, and its relationship with clinical pathological parameters and patient prognosis. Methods ZNF703 was probed for by immunohistochemical SP in 81 ovarian tissues(45 cases of ovarian serous malignant tumor, 12 cases of ovarian serous borderline tumor, 13 cases of ovarian serous benign tumor, and 11 normal ovarian tissue samples). The relationship between ZNF703 expression and clinicopathological parameters, and its influence on survival and prognosis of patients with ovarian serous carcinoma were assessed. Results ZNF703 was mainly expressed in nuclei, with a small amount of cytoplasmic expression. ZNF703 expression was significantly increased in ovarian serous carcinoma relative to expression in serous borderline tumors, serous benign tumors, and normal ovarian tissue. High ZNF703 expression was related to the patient's stage(P<0.01), but not significantly related to differentiation or lymph node metastasis. Survival time of patients with high ZNF703 expression was significantly shortened(P=0.011). Conclusion As a prognostic factor for ovarian cancer, ZNF703 is expected to be useful as a biomarker for ovarian cancer to monitor and guide treatment of ovarian cancer patients.
Key words: ovarian epithelial serous tumor, immunohistochemistry, zinc finger protein 703
PDF全文下载地址:
https://journal.cmu.edu.cn/CN/article/downloadArticleFile.do?attachType=PDF&id=2906